Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment

ABSTRACT Nanotechnology has been extensively utilized in the design and development of powerful strategies for drug delivery and cancer theranostic. Nanoplatforms as a drug delivery system have many advantages such as in vivo imaging, combined drug delivery, extended circulation time, and systemic controlled release. The functional biomimetic drug delivery could be realized by incorporating stimuli-responsive (pH, temperature, redox potential, etc.) properties into the nanocarrier system, allowing them to bypass biological barriers and arrive at the targeted area. In this review, we discuss the role of internal stimuli-responsive nanocarrier system for imaging and drug delivery in cancer therapy. The development of internal stimuli-responsive nanoparticles is highlighted for precision drug delivery applications, with a particular focus on in vivo imaging, drug release performance, and therapeutic benefits. Graphical Abstract

[1]  Xianlei Li,et al.  In Situ Monitoring of MicroRNA Replacement Efficacy and Accurate Imaging‐Guided Cancer Therapy through Light‐Up Inter‐Polyelectrolyte Nanocomplexes , 2018, Advanced science.

[2]  Yiguang Jin,et al.  Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment. , 2013, Colloids and surfaces. B, Biointerfaces.

[3]  S. Hurley,et al.  Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging. , 2010, ACS nano.

[4]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[5]  R. Langer,et al.  Poly(Ethylene Oxide)-Modified Poly(β-Amino Ester) Nanoparticles as a pH-Sensitive System for Tumor-Targeted Delivery of Hydrophobic Drugs: Part 2. In Vivo Distribution and Tumor Localization Studies , 2005, Pharmaceutical Research.

[6]  S. Brocchini,et al.  Polyacetal-doxorubicin conjugates designed for pH-dependent degradation. , 2003, Bioconjugate chemistry.

[7]  Q. Dong,et al.  Injectable and Biodegradable pH-Responsive Hydrogels for Localized and Sustained Treatment of Human Fibrosarcoma. , 2015, ACS applied materials & interfaces.

[8]  A. Awada,et al.  Molecular targeted therapy in prevalent tumors: learning from the past and future perspectives. , 2010, Current Clinical Pharmacology.

[9]  Weihong Zhu,et al.  Multifunctional Shell–Core Nanoparticles for Treatment of Multidrug Resistance Hepatocellular Carcinoma , 2018 .

[10]  K. Kono,et al.  Gene delivery to dendritic cells mediated by complexes of lipoplexes and pH-sensitive fusogenic polymer-modified liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[11]  T. Fojo,et al.  Strategies for reversing drug resistance , 2003, Oncogene.

[12]  Jinming Hu,et al.  Enzyme-responsive polymeric assemblies, nanoparticles and hydrogels. , 2012, Chemical Society reviews.

[13]  K. Kono,et al.  A liposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy. , 2013, Biomaterials.

[14]  Taeghwan Hyeon,et al.  Multifunctional tumor pH-sensitive self-assembled nanoparticles for bimodal imaging and treatment of resistant heterogeneous tumors. , 2014, Journal of the American Chemical Society.

[15]  Rein V. Ulijn,et al.  Enzyme-responsive materials: a new class of smart biomaterials , 2006 .

[16]  S. Pispas,et al.  Curcumin loaded pH-sensitive hybrid lipid/block copolymer nanosized drug delivery systems. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[17]  P. Holloway,et al.  Enhanced and stable green emission of ZnO nanoparticles by surface segregation of Mg , 2006, Nanotechnology.

[18]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[19]  M. Ogris,et al.  Acetal linked oligoethylenimines for use as pH-sensitive gene carriers. , 2008, Bioconjugate chemistry.

[20]  S. Aluri,et al.  Environmentally responsive peptides as anticancer drug carriers. , 2009, Advanced drug delivery reviews.

[21]  George W. Sledge,et al.  Decade in review—targeted therapy: Successes, toxicities and challenges in solid tumours , 2014, Nature Reviews Clinical Oncology.

[22]  P. Gupta,et al.  Hydrogels: from controlled release to pH-responsive drug delivery. , 2002, Drug discovery today.

[23]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[24]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .

[25]  E. Mahmoud,et al.  Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide. , 2012, Journal of the American Chemical Society.

[26]  Thomas L Andresen,et al.  Enzyme-triggered nanomedicine: Drug release strategies in cancer therapy (Invited Review) , 2010, Molecular membrane biology.

[27]  Miqin Zhang,et al.  Chitosan-based hydrogels for controlled, localized drug delivery. , 2010, Advanced drug delivery reviews.

[28]  P. D. Drummond,et al.  QUANTUM THEORY OF DISPERSIVE ELECTROMAGNETIC MODES , 1998 .

[29]  S. Ganta,et al.  A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Pixin Wang,et al.  Fabrication and characterization of microstructured and pH sensitive interpenetrating networks hydrogel films and application in drug delivery field , 2009 .

[31]  Baoan Chen,et al.  Daunorubicin-TiO2 nanocomposites as a “smart” pH-responsive drug delivery system , 2011, International journal of nanomedicine.

[32]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[33]  Yi-Ting Chiang,et al.  pH-responsive polymer-liposomes for intracellular drug delivery and tumor extracellular matrix switched-on targeted cancer therapy. , 2014, Biomaterials.

[34]  Xingyu Jiang,et al.  pH Switchable Nanoassembly for Imaging a Broad Range of Malignant Tumors. , 2017, ACS nano.

[35]  Yun Chen,et al.  Core/shell pH‐sensitive micelles self‐assembled from cholesterol conjugated oligopeptides for anticancer drug delivery , 2009 .

[36]  Huijun Zhao,et al.  Acid degradable ZnO quantum dots as a platform for targeted delivery of an anticancer drug , 2011 .

[37]  M. Stevens,et al.  Enzyme‐Responsive Nanoparticle Systems , 2008 .

[38]  F. Tamanoi,et al.  Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells , 2015, PloS one.

[39]  B. Rouse,et al.  pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein. , 1991, Journal of immunological methods.

[40]  Ying Li,et al.  Dual redox responsive assemblies formed from diselenide block copolymers. , 2010, Journal of the American Chemical Society.

[41]  Lin Yu,et al.  A delicate ionizable-group effect on self-assembly and thermogelling of amphiphilic block copolymers in water , 2009 .

[42]  S. Noguchi,et al.  Immunohistochemical, ultrastructural and biochemical studies of an amylase-producing breast carcinoma , 2005, Virchows Archiv A.

[43]  Zhenping Cheng,et al.  Self-assembly of BODIPY based pH-sensitive near-infrared polymeric micelles for drug controlled delivery and fluorescence imaging applications. , 2015, Nanoscale.

[44]  Edward Chu,et al.  A history of cancer chemotherapy. , 2008, Cancer research.

[45]  T. Ishida,et al.  Development of pH-sensitive liposomes that efficiently retain encapsulated doxorubicin (DXR) in blood. , 2006, International journal of pharmaceutics.

[46]  Katie M. Reindl,et al.  MMP-9 Responsive PEG Cleavable Nanovesicles for Efficient Delivery of Chemotherapeutics to Pancreatic Cancer , 2014, Molecular pharmaceutics.

[47]  S. Yadav,et al.  Azobenzene-aminoglycoside: Self-assembled smart amphiphilic nanostructures for drug delivery. , 2015, Colloids and surfaces. B, Biointerfaces.

[48]  M. Amiji,et al.  Poly(ethylene oxide)-modified poly(ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer , 2005 .

[49]  Liangfang Zhang,et al.  Therapeutic nanoparticles to combat cancer drug resistance. , 2009, Current drug metabolism.

[50]  C. Anthony Hunt,et al.  Engineering Targeted In Vivo Drug Delivery. I. The Physiological and Physicochemical Principles Governing Opportunities and Limitations , 1986, Pharmaceutical Research.

[51]  Swarnlata Saraf,et al.  Nanocarriers: promising vehicle for bioactive drugs. , 2006, Biological & pharmaceutical bulletin.

[52]  Shanshan Huang,et al.  Poly(Acrylic Acid) Modification of Nd3+‐Sensitized Upconversion Nanophosphors for Highly Efficient UCL Imaging and pH‐Responsive Drug Delivery , 2015 .

[53]  S. Rakshit,et al.  Trap-state dynamics in visible-light-emitting ZnO:MgO nanocrystals , 2008 .

[54]  Quanyin Hu,et al.  Enzyme-responsive nanomaterials for controlled drug delivery. , 2014, Nanoscale.

[55]  K. Kono,et al.  Dextran derivative-based pH-sensitive liposomes for cancer immunotherapy. , 2014, Biomaterials.

[56]  H Harashima,et al.  Intracellular regulation of macromolecules using pH-sensitive liposomes and nuclear localization signal: qualitative and quantitative evaluation of intracellular trafficking. , 1998, Biochemical and biophysical research communications.

[57]  J. Anzai,et al.  Layer-by-layer assembled thin films composed of carboxyl-terminated poly(amidoamine) dendrimer as a pH-sensitive nano-device. , 2008, Journal of colloid and interface science.

[58]  Zhiyuan Zhong,et al.  pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[59]  R. Zhuo,et al.  Peptide decorated calcium phosphate/carboxymethyl chitosan hybrid nanoparticles with improved drug delivery efficiency. , 2013, International journal of pharmaceutics.

[60]  G. Kwon,et al.  Mixed pH-Sensitive Polymeric Micelles for Combination Drug Delivery , 2010, Pharmaceutical Research.

[61]  F. Szoka,et al.  Secondary structure and orientation of the amphipathic peptide GALA in lipid structures. An infrared-spectroscopic approach. , 1991, European journal of biochemistry.

[62]  V. Cardoso,et al.  Long-circulating, pH-sensitive liposomes versus long-circulating, non-pH-sensitive liposomes as a delivery system for tumor identification. , 2013, Journal of biomedical nanotechnology.

[63]  Younan Xia,et al.  A reactive oxygen species (ROS)-responsive polymer for safe, efficient, and targeted gene delivery in cancer cells. , 2013, Angewandte Chemie.

[64]  A. La Cava,et al.  Potential for anti-DNA immunoglobulin peptide therapy in systemic lupus erythematosus , 2009 .

[65]  Jean Campbell,et al.  Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[66]  J. K. Kundu,et al.  Nrf2-Keap1 Signaling as a Potential Target for Chemoprevention of Inflammation-Associated Carcinogenesis , 2010, Pharmaceutical Research.

[67]  R. Ho,et al.  Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA. , 2017, Acta biomaterialia.

[68]  K. Kono,et al.  Improvement of Peptide-Based Tumor Immunotherapy Using pH-Sensitive Fusogenic Polymer-Modified Liposomes , 2016, Molecules.

[69]  Yuan Gao,et al.  Enzyme-Instructed Self-assembly in Biological Milieu for Theranostics Purpose. , 2019, Current medicinal chemistry.

[70]  P. Cullis,et al.  Drug Delivery Systems: Entering the Mainstream , 2004, Science.

[71]  Jing Qin,et al.  Multifunctional drug delivery system for targeting tumor and its acidic microenvironment. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[72]  Molly M Stevens,et al.  Enzyme-responsive nanoparticles for drug release and diagnostics. , 2012, Advanced drug delivery reviews.

[73]  James H. Adair,et al.  Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. , 2008, Nano letters.

[74]  H. Kamohara,et al.  Group II phospholipase A2 is increased in peritoneal and pleural effusions in patients with various types of cancer , 1997, International journal of cancer.

[75]  M. Stevens,et al.  Kinase-actuated immunoaggregation of Peptide-conjugated gold nanoparticles. , 2010, Small.

[76]  S. Parveen,et al.  Polymeric nanoparticles for cancer therapy , 2008, Journal of drug targeting.

[77]  C. Catterall,et al.  THE TRANSFECTION OF JURKAT T-LEUKEMIC CELLS BY USE OF PH-SENSITIVE IMMUNOLIPOSOMES , 2002, Journal of liposome research.

[78]  Yasuo Shinohara,et al.  Mitochondrial delivery of mastoparan with transferrin liposomes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy. , 2005, International journal of pharmaceutics.

[79]  D. Cui,et al.  MMP2-Targeting and Redox-Responsive PEGylated Chlorin e6 Nanoparticles for Cancer Near-Infrared Imaging and Photodynamic Therapy. , 2016, ACS applied materials & interfaces.

[80]  Tej B. Shrestha,et al.  Protease-sensitive, polymer-caged liposomes: a method for making highly targeted liposomes using triggered release. , 2011, ACS nano.

[81]  Caleb F. Anderson,et al.  Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging , 2017, Industrial & engineering chemistry research.

[82]  Jing Cao,et al.  Yolk-shell hybrid nanoparticles with magnetic and pH-sensitive properties for controlled anticancer drug delivery. , 2013, Nanoscale.

[83]  You Han Bae,et al.  Recent progress in tumor pH targeting nanotechnology. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[84]  Ting Cai,et al.  In Vivo Targeting and Positron Emission Tomography Imaging of Tumor with Intrinsically Radioactive Metal-Organic Frameworks Nanomaterials. , 2017, ACS nano.

[85]  T. Kasama,et al.  Analysis of glycosphingolipids of human head and neck carcinomas with comparison to normal tissue , 1998, Biochemistry and molecular biology international.

[86]  Song Li,et al.  Nanomicellar carriers for targeted delivery of anticancer agents. , 2014, Therapeutic delivery.

[87]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[88]  M. Stevens,et al.  Single-step kinase inhibitor screening using a peptide-modified gold nanoparticle platform. , 2011, Chemical communications.

[89]  R. Haag,et al.  Functional dendritic polymer architectures as stimuli-responsive nanocarriers. , 2010, Biochimie.

[90]  B. Tang,et al.  Peptide-Based Treatment: A Promising Cancer Therapy , 2015, Journal of immunology research.

[91]  Xiaoyuan Chen,et al.  Hierarchical Targeting Strategy for Enhanced Tumor Tissue Accumulation/Retention and Cellular Internalization , 2016, Advanced materials.

[92]  R. Singhal,et al.  Poly (glutamic acid)--an emerging biopolymer of commercial interest. , 2011, Bioresource technology.

[93]  Tana,et al.  pH-Sensitive fusogenic polymer-modified liposomes as a carrier of antigenic proteins for activation of cellular immunity. , 2010, Biomaterials.

[94]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[95]  Yanli Zhao,et al.  A Transferrin-Conjugated Hollow Nanoplatform for Redox-Controlled and Targeted Chemotherapy of Tumor with Reduced Inflammatory Reactions , 2018, Theranostics.

[96]  K. Ulbrich,et al.  Polymeric micellar pH-sensitive drug delivery system for doxorubicin. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[97]  Jie Feng,et al.  Multifunctional Mesoporous Silica Nanoparticles Based on Charge-Reversal Plug-Gate Nanovalves and Acid-Decomposable ZnO Quantum Dots for Intracellular Drug Delivery. , 2015, ACS applied materials & interfaces.

[98]  J. Eckfeldt,et al.  A unique case of breast carcinoma producing pancreatic-type isoamylase. , 1988, Gastroenterology.

[99]  E. Gil,et al.  Stimuli-reponsive polymers and their bioconjugates , 2004 .

[100]  He Zhang,et al.  Complexes containing cationic and anionic pH-sensitive liposomes: comparative study of factors influencing plasmid DNA gene delivery to tumors , 2013, International journal of nanomedicine.

[101]  F. Szoka,et al.  pH-dependent bilayer destabilization by an amphipathic peptide. , 1987, Biochemistry.

[102]  Felix Kratz,et al.  Polymer therapeutics: concepts and applications. , 2006, Angewandte Chemie.

[103]  Younan Xia,et al.  Smart multifunctional hollow microspheres for the quick release of drugs in intracellular lysosomal compartments. , 2011, Angewandte Chemie.

[104]  L. Canham.  Nanosilicon for nanomedicine: a step towards biodegradable electronic implants? , 2013, Nanomedicine.

[105]  D. Schmaljohann.  Thermo- and pH-responsive polymers in drug delivery. , 2006, Advanced drug delivery reviews.

[106]  Juan Carlos Vidal,et al.  Phase I and pharmacokinetics study of crotoxin (cytotoxic PLA(2), NSC-624244) in patients with advanced cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[107]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[108]  P. Borst,et al.  Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.

[109]  T. Andresen,et al.  Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids. , 2004, Molecular cancer therapeutics.

[110]  J. Mauzeroll,et al.  Ferrocene-Modified Phospholipid: An Innovative Precursor for Redox-Triggered Drug Delivery Vesicles Selective to Cancer Cells. , 2016, Langmuir : the ACS journal of surfaces and colloids.

[111]  J. Leroux,et al.  In vitro characterization of a novel polymeric-based pH-sensitive liposome system. , 2000, Biochimica et biophysica acta.

[112]  Tingxian Liu,et al.  Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer. , 2014, Nanoscale.

[113]  D. Butterfield,et al.  Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration. , 2010, Journal of Alzheimer's disease : JAD.

[114]  Vladimir P Torchilin,et al.  pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. , 2013, Biomaterials.

[115]  Vladimir Torchilin,et al.  Stimuli-sensitive nanopreparations for combination cancer therapy. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[116]  Mansoor Amiji,et al.  Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations. , 2005, Molecular pharmaceutics.

[117]  T. Young,et al.  Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[118]  H. Takeuchi,et al.  pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[119]  M. Amiji,et al.  Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. , 2005, International journal of pharmaceutics.

[120]  F. Szoka,et al.  GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. , 2004, Advanced drug delivery reviews.

[121]  Yuki Takahashi,et al.  Enhanced Class I Tumor Antigen Presentation via Cytosolic Delivery of Exosomal Cargos by Tumor-Cell-Derived Exosomes Displaying a pH-Sensitive Fusogenic Peptide. , 2017, Molecular pharmaceutics.

[122]  L. Gerweck,et al.  Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.

[123]  Jonathan W Aylott,et al.  Protease sensing with nanoparticle based platforms. , 2011, The Analyst.

[124]  R. K. Mishra,et al.  pH dependent poly[2-(methacryloyloxyethyl)trimetylammonium chloride-co-methacrylic acid]hydrogels for enhanced targeted delivery of 5-fluorouracil in colon cancer cells , 2014, Journal of Materials Science: Materials in Medicine.

[125]  Vladimir P Torchilin,et al.  Multifunctional nanocarriers. , 2006, Advanced drug delivery reviews.

[126]  D. Papahadjopoulos,et al.  Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.

[127]  J. Yamashita,et al.  Increased expression of membrane‐associated phospholipase A2 shows malignant potential of human breast cancer cells , 1993, Cancer.

[128]  Jia Guo,et al.  Biodegradation and Toxicity of Protease/Redox/pH Stimuli-Responsive PEGlated PMAA Nanohydrogels for Targeting Drug delivery. , 2015, ACS applied materials & interfaces.

[129]  L. Huang,et al.  Liposome-mediated cytoplasmic delivery of proteins: an effective means of accessing the MHC class I-restricted antigen presentation pathway. , 1994, ImmunoMethods.

[130]  R. Zhuo,et al.  A redox-responsive drug delivery system based on RGD containing peptide-capped mesoporous silica nanoparticles. , 2015, Journal of materials chemistry. B.

[131]  Hyewon Youn,et al.  Cyclodextrin-covered gold nanoparticles for targeted delivery of an anti-cancer drug , 2009 .

[132]  K. Kono,et al.  pH-sensitive polymer-liposome-based antigen delivery systems potentiated with interferon-γ gene lipoplex for efficient cancer immunotherapy. , 2015, Biomaterials.

[133]  Xiaoyuan Chen,et al.  Stimuli-Responsive Programmed Specific Targeting in Nanomedicine. , 2016, ACS nano.

[134]  M. Amiji,et al.  Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. , 2005, Bioconjugate chemistry.

[135]  H. Hui,et al.  Thermo- and pH-sensitive dendrimer derivatives with a shell of poly(N,N-dimethylaminoethyl methacrylate) and study of their controlled drug release behavior , 2005 .

[136]  Elena Aznar,et al.  Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides". , 2010, ACS nano.

[137]  J. Haveman,et al.  The relevance of tumour pH to the treatment of malignant disease. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[138]  Xing-jie Liang,et al.  CO2 gas induced drug release from pH-sensitive liposome to circumvent doxorubicin resistant cells. , 2012, Chemical communications.

[139]  F. Szoka,et al.  pH-dependent fusion of phosphatidylcholine small vesicles. Induction by a synthetic amphipathic peptide. , 1988, The Journal of biological chemistry.

[140]  I. Tetko,et al.  Extended Functional Groups (EFG): An Efficient Set for Chemical Characterization and Structure-Activity Relationship Studies of Chemical Compounds , 2015, Molecules.

[141]  Lei Lu,et al.  pH-Triggered Release of Hydrophobic Molecules from Self-Assembling Hybrid Nanoscaffolds. , 2016, Biomacromolecules.

[142]  Nick S. Norberg,et al.  Influence of surface modification on the luminescence of colloidal ZnO nanocrystals. , 2005, The journal of physical chemistry. B.

[143]  R Langer,et al.  Responsive polymeric delivery systems. , 2001, Advanced drug delivery reviews.

[144]  F. Szoka,et al.  Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA. , 1990, Biochemistry.